The FDA recently warned that Americans have gotten very sick from overdosing on compounded semaglutide, noting that in some cases, people have inadvertently taken 20 times the required dose
Dumril, 1854) Indonesia (Sulawesi)
Has Taken a GLP-1 Drug and Food Brands Are Taking Notice, January 2025 17 Beckers Hospital Review, Bariatric surgeries plunge in GLP-1 era: New study, October 2024 18 TCTMD, Could Pricey GLP-1 Drugs Cut Healthcare Costs
average body-weight loss with semaglutide STEP-1 trial (NEJM) average body-weight loss with tirzepatide SURMOUNT-1 trial (NEJM) lower risk of major heart events SELECT trial (NEJM) Figures are from peer-reviewed clinical trials of the active ingredients (semaglutide and tirzepatide), not a guarantee of individual results
They're brand-stated, not independent guarantees of approval, pricing, results, or safety, and "What to Verify" points to the buyer checklist in this article rather than to any lab testing performed by this publication
Socioeconomic Factors There is a well-established link between socioeconomic status and obesity